Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 16 of 16 for “"Beta interferon"”.
-
Policy networks in healthcare policy: a case study on the National Institute for Clinical Excellence and the appraisal for beta-interferon treatment for patients with multiple sclerosis
The focus of this thesis was the study of the policy decision-making process in the healthcare services network in order to understand the behaviour of key actors involved in the UK health network. Additionally, the study examined about the use of the “policy networks” approach, and the application …
-
Investigation of the Role of Membrane Glycosides in the Cellular Response to IFN-α/β and Interleukin 2
… L1210R, are sensitive and resistant to (alpha)/(beta) -interferon respectively. The L1210R cells are thought to differ from the L1210S in only two properties: (1) they lack the high affinity binding sites (receptors) present for (alpha)/(beta)-interferon on the L1210S, and (2) they are more …
-
The Adaptation of Chinese Hamster Ovary Cells to Hypothermic Temperatures Increases Yields of Monomeric Recombinant Interferon-beta
… level of cell specific expression of recombinant beta-interferon. The volumetric titre of beta-interferon was enhanced by 70% in stationary cultures and by more than 2-fold by application of a temperature-shift strategy involving a growth to production phase. However, the low temperature-adapted …
-
Esclerose múltipla no Brasil : estudo de custo da doença e de custo-efetividade dos tratamentos disponíveis no país
… disponíveis para a EM no Brasil, ou seja, o beta-interferon 1b, beta-interferon 1a intramuscular, beta-interferon 1a sub-cutâneo, acetato de glatiramer, natalizumabe, e fingolimode. O custo geral de cada paciente com EM ao longo de 1 ano foi de R$ 22.648,12 , sendo que 0,4% foi devido a …
-
Causal inference approaches for dealing with time-dependent confounding in longitudinal studies, with applications to multiple sclerosis research
… confounding while assessing the effects of beta-interferon drug exposure on disease progression in relapsing-remitting multiple sclerosis (MS) patients in the real-world clinical practice setting. In the context of this chronic, yet fluctuating disease, MSCMs were used to adjust for the …
-
Comparison of first-line therapies for relapsing-remitting multiple sclerosis
… started on one of four first-line therapies (beta interferon, glatiramer acetate, teriflunomide, or dimethyl fumarate). Though there are distinct differences between these treatments in regard to efficacy and safety, there is no uniform standard for making decisions about which to initiate …
-
MRI lesion activity in relapsing-remitting patients with multiple sclerosis
… relapsing-remitting MS patients, as part of a beta-interferon trial, were examined every 6 weeks with MRI for a 2 year period in this study. The patients were randomized into three treatment arms: placebo (N=17), 1.6 mlU (N=17), and 8 mlU (N=16) beta-interferon self-administered subcutaneously …
-
EFFECTS OF INTERFERON TREATMENT ON HBV PRE-CORE MUTANTS IN CHRONIC HEPATITIS B CARRIERS IN SINGAPORE
… pre-core variants and their relationship to interferon treatment in chronic hepatitis B carriers were investigated. Ten chronic hepatitis B carriers (8 male, 2 female; age range 28-53yrs; 6 chronic active hepatitis (CAH), 4 chronic persistent hepatitis (CPH)) were given beta-interferon …
-
Development of an Animal Model for Enterovirus for Evaluation D68 for Screening of Antiviral Therapies
… model, 4-week old AG129 mice that lack alpha and beta interferon receptors, making them immunosuppressed, were used. The mice were infected with EV-D68 by the intranasal route to allow infection of the lungs. On day-3 post-infection the mice were euthanized and lungs were removed and homogenized …
-
Analysis of bovine tonsils and trigeminal ganglia following infection with bovine herpesvirus type 1 (BHV-1) or a BHV-1 latency-related mutant strain
… tissues after acute infection. Furthermore, beta interferon RNA expression was higher in tonsils, and occurred earlier in bovine cells following infection with the LR mutant. Expression of the IFN-γ-receptor was exclusively detected in TG of calves latently infected with wt BHV-1, suggesting …
-
Exploitation of Ebola Virus VP35 Protein to identify new drugs counteracting its type I IFN antagonism
… assembly. Early during EBOV infection, alpha-beta interferon (IFN-α/β) production would be triggered upon recognition of viral dsRNA products by cytoplasmic retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs). However, this recognition is efficiently prevented by the double-stranded …
-
Mechanisms of CD8+ T Cell Mediated Virus Inhibition in HIV-1 Virus Controllers
… inflammatory proteins (MIP-1α, MIP-1αP, MIP-1β), interferon gamma (IFN-γ), granulocyte-macrophage colony-stimulating factor (GM-CSF), and recently identified lymphotactin (XCL1). </p><p>Our previous work suggests the CD8+ T-cell response to HIV-1 can be regulated at the level of gene regulation. …
-
Roles of IFN-Alpha/Beta and IFN-Gamma in Enhancing and Inhibiting NK Cell Mediated Killing of Oncolytic Virus Infected Tumor Cells
Type I interferon (IFN-I) and interferon-gamma (IFN-γ) are potent cytokines that can be produced by virus-infected cells and Natural Killer (NK) cells, respectively. The relative roles of these two IFNs in promoting NK cell killing of tumor cells was tested in the context of combining …
-
Regulation of rainbow trout (Oncorhynchus mykiss) mRNA at the innate/adaptive immunity interface in response to Vibrogen 2
Aquaculture supplies the world market with over 50% of food fish and is an economically important industry, however limited disease management strategies often lead to significant economic losses and/or poor-quality product. Historically, antibiotics were used prophylactically and as a treatment in …
-
Distinct Functions for Type I and Type II Interferon in Cancer Immunoediting
… led to the cancer immunoediting hypothesis. The interferons, both type I: IFNα/β) and type II IFN: IFNγ), are critical mediators of cancer immunoediting, yet their respective roles in promoting anti-tumor immune responses remain unclear. Herein, we have examined the actions of IFNα/β and IFNγ …